Multiplikator Forward P/S: Carlsmed (CARL)

Carlsmed Inc - logo grafis emiten CARL

The investment potential of Carlsmed Inc (CARL) is driven by Cheryl Blanchard's expertise in developing breakthrough surgical solutions. The forward P/S ratio on the GURU.Markets chart illustrates the valuation trend, where the metric stands at 6.50. Strict FDA requirements and unique patents for AI implants serve as the foundation. Focused management and the confidence of major institutional investors in the secure software ensure price stability.

carlsmed.com - Kapitalisasi marang prakiraan pendapatan CARL (periode 24.07.2025 - 15.11.2026)

Ringkesan rincian data analitis Carlsmed Inc (CARL)

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Analisis fundamental perusahaan:CARL (Carlsmed Corp)
Sampel barang Carlsmed Medical

To minimize the risk of asset undervaluation, it is essential to correlate market value with expected revenue, which is critical for Carlsmed Inc. (CARL) and its high-margin JIT delivery model for customized implants. By analyzing the forward P/S trend, an investor determines the value of each projected dollar of sales, assessing how effectively the market prices in the future expansion of digital manufacturing and the operational resilience of the business.

Karo sapa Carlsmed Inc saingan

Multiplikator Forward P/S BSX (bostonscientific.com)|EW: Kapitalisasi marang prakiraan pendapatan|ResMed - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Corporation|ZBH: Multiplikator Forward P/S|COO - Rasio kapitalisasi marang dodolan sing dikarepake|ALGN (Align Corp) - Multiplikator Forward P/S|Globus Medical Corp (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Holdings, Inc. ATEC|Multiplikator Forward P/S AORT (artivion.com)|Multiplikator Forward P/S Enovis Corp ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Inc) - Multiplikator forward rega marang pendapatan|IRADIMED CORPORATION - Rega forward marang dodolan|EMBC (Embecta Health) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tandem Diabetes Care Inc TNDM|Rasio rega marang prakiraan pendapatan AxoGen Inc (AXGN)|SI-BONE, Inc. (SIBN) - Prakiraan rega marang pendapatan|Orthofix Corp - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake bioventus.com (BVS)|OrthoPediatrics Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Treace Medical Concepts Inc TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RXST (RxSight Ophthalmic)|Rasio rega marang prakiraan pendapatan clearpointneuro.com|Multiplikator forward rega marang pendapatan Stereotaxis, Inc. (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical - Rasio rega marang pendapatan sing dikarepake|VANI (Vivani Medical Inc) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan XTNT|NMTC (n1mtc.com) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Modular Medical MODD|Rasio rega marang prakiraan pendapatan myomo.com (MYO)|Rasio rega marang prakiraan pendapatan COCH (envoymedical.com)|Rasio rega marang prakiraan pendapatan Vivos Therapeutics Inc VVOS|enVVeno Medical Corp. - Rasio rega marang prakiraan pendapatan|SINT: Multiplikator forward rega marang pendapatan|TNON (Tenon Medical, Inc.) - Kapitalisasi marang prakiraan pendapatan|Lifeward Ltd. (LFWD) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Autonomix (AMIX)|Rasio rega marang prakiraan pendapatan INVO Fertility|Bone Biologics Corp. (BBLG) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan AXNX (Axonics Modulation Technologies)|BIOL (Biolase, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S DYNT (dynatronics.com)|Rega forward marang dodolan FNA|INVO Bioscience - Multiplikator Forward P/S